Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR
X4 Pharmaceuticals (XFOR) Stock Price & Analysis
627 Followers
XFOR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.65 - $2.41
Previous Close$1.93
Volume2.95M
Average Volume (3M)3.05M
Market Cap
$243.63M
Enterprise Value$145.63M
Total Cash (Recent Filing)$93.41M
Total Debt (Recent Filing)$5.11M
Price to Earnings (P/E)-1.5
Beta1.25
Next Earnings
Aug 03, 2023EPS Estimate
-$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.31
Shares Outstanding122,207,488
10 Day Avg. Volume7,061,886
30 Day Avg. Volume3,050,632
Standard Deviation0.35
R-Squared0.01
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)4813.48
Price to Cash Flow (P/CF)N/A
P/FCF Ratio40.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue990.68
Enterprise Value/Gross Profit743.01
Enterprise Value/Ebitda-2.12
Forecast
1Y Price Target
$3.79Price Target Upside86.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
X4 Pharmaceuticals News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
XFOR FAQ
What was X4 Pharmaceuticals Inc’s price range in the past 12 months?
X4 Pharmaceuticals Inc lowest stock price was $0.65 and its highest was $2.41 in the past 12 months.
What is X4 Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is X4 Pharmaceuticals Inc’s upcoming earnings report date?
X4 Pharmaceuticals Inc’s upcoming earnings report date is Aug 03, 2023 which is in 63 days.
How were X4 Pharmaceuticals Inc’s earnings last quarter?
X4 Pharmaceuticals Inc released its earnings results on May 04, 2023. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.212 by $0.052.
Is X4 Pharmaceuticals Inc overvalued?
According to Wall Street analysts X4 Pharmaceuticals Inc’s price is currently Undervalued.
Does X4 Pharmaceuticals Inc pay dividends?
X4 Pharmaceuticals Inc does not currently pay dividends.
What is X4 Pharmaceuticals Inc’s EPS estimate?
X4 Pharmaceuticals Inc’s EPS estimate is -$0.16.
How many shares outstanding does X4 Pharmaceuticals Inc have?
X4 Pharmaceuticals Inc has 121,207,490 shares outstanding.
What happened to X4 Pharmaceuticals Inc’s price movement after its last earnings report?
X4 Pharmaceuticals Inc reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.212. Following the earnings report the stock price went up 4.054%.
Which hedge fund is a major shareholder of X4 Pharmaceuticals Inc?
Among the largest hedge funds holding X4 Pharmaceuticals Inc’s share is Perceptive Advisors LLC. It holds X4 Pharmaceuticals Inc’s shares valued at 4M.
---
X4 Pharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$3.79 (86.70% Upside)
$3.79 (86.70% Upside)
Blogger Sentiment
Bullish
XFOR Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 4.5M Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.40%
12-Months-Change
Fundamentals
Return on Equity
-189.21%
Trailing 12-Months
Asset Growth
24.87%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
X4 Pharmaceuticals Inc
X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding XFOR
iShares Core S&P Total U.S. Stock Market ETF
$40.02K
Up to five ETFs with an Outperform Smart Score that hold XFOR. The ETFs are listed according to market value of XFOR within the ETF
---
Corvus Pharmaceuticals
―
Voyager Therapeutics
―
Kala Pharmaceuticals
―
Adverum Biotechnologies
―
---